FASEB's Transcription, Chromatin and Epigenetics in Aging Conference
FASEB 衰老会议中的转录、染色质和表观遗传学
基本信息
- 批准号:10312653
- 负责人:
- 金额:$ 5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-01 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAddressAgeAgingAmazeAnimal ModelAreaBiological ModelsCell AgingCell physiologyCellsChromatinChromatin StructureCollaborationsDNADevelopmentDisciplineDiseaseEducational workshopEpigenetic ProcessEventExplosionFosteringFundingFutureGap JunctionsGenderGenetic TranscriptionGenomeGoalsHealthHumanIndividualInternationalInterventionItalyKnowledgeLearningMalignant NeoplasmsMeasuresMethodologyMicroscopyMolecularPhysiciansPlayPost-Translational Protein ProcessingRNARegulationRejuvenationResearchResearch PersonnelResolutionRoleScienceScientistSicilyTechnologyTherapeuticTimeTranscriptional RegulationTranslatingUnderrepresented PopulationsWorkage relatedanti agingcareer developmentchromatin modificationepigenetic regulationepigenomicsfrontiergrasphistone modificationhuman diseaseimprovedinnovationinsightinterdisciplinary collaborationinterestmeetingsnormal agingnovelnovel therapeutic interventionpostersregenerative cellsingle cell technologysingle moleculesymposiumtool
项目摘要
SUMMARY
The goal of this FASEB meeting “Transcription, Chromatin and Epigenetics in Aging” is to cover
the role new epigenetic mechanisms in the regulation of aging and in ‘rejuvenation’ strategies for
age-related diseases. Epigenetic mechanisms encompass post-translational modifications of
chromatin and RNA as well as transcriptional regulation. This FASEB meeting will be unique in
integrating the latest discoveries in epigenetics and their importance in aging and ‘rejuvenation’
strategies for age-related diseases. There is a vital need for such a meeting. Exciting recent
studies have revealed how organismal and cellular aging can be regulated by epigenetic
mechanisms. The field of epigenetic is rapidly expanding, and the aging field needs to benefit
from the latest and greatest discoveries in this area. Conversely, challenges and questions about
the role of epigenetics in aging and age-related diseases abound, and it is critical for researchers
in the chromatin and transcription fields to better grasp the implications of their work for health
and disease.
This FASEB meeting will discuss the most cutting-edge questions in field of chromatin,
transcription, and epigenetics. A key topic will be the underlying molecular basis of epigenetic
mechanisms. The question of how these mechanisms get dysregulated during normal aging and
disease will also be discussed. The meeting will also cover new frontiers, including the exciting
emerging field of three-dimensional chromatin structure and RNA epigenomics. The meeting will
particularly focus on transformative epigenomic technologies at the single cell and single molecule
levels and how they can be used to build and use ‘epigenetic clocks’ in cells from individuals at
different ages and to identify novel ‘rejuvenation’ strategies for different age-related diseases.
This meeting should foster exciting fundamental knowledge and information, new methodology
and technical capabilities, and interdisciplinary collaborations. The meeting will also provide a
uniquely interactive, diverse, and inclusive forum for trainees and new investigators in very
different areas, highlighting their research through short talks, poster teasers and sessions and
promoting several networking and meet-the-expert events.
概括
本次 FASEB 会议“衰老中的转录、染色质和表观遗传学”的目标是涵盖
新的表观遗传机制在衰老调节和“返老还童”策略中的作用
与年龄相关的疾病。
这次 FASEB 会议在染色质和 RNA 以及转录调控方面将是独一无二的。
整合表观遗传学的最新发现及其在衰老和“返老还童”中的重要性
最近迫切需要召开这样一次令人兴奋的会议。
研究揭示了表观遗传如何调节生物和细胞衰老
表观遗传学领域正在迅速扩大,老龄化领域需要受益。
来自该领域的最新和最伟大的发现、挑战和问题。
表观遗传学在衰老和与年龄相关的疾病中的作用比比皆是,对研究人员来说至关重要
在染色质和转录领域更好地掌握他们的工作对健康的影响
和疾病。
本次FASEB会议将讨论染色质领域最前沿的问题,
转录和表观遗传学的一个关键主题是表观遗传学的分子基础。
这些机制在正常衰老过程中如何失调的问题。
会议还将讨论新的领域,包括令人兴奋的领域。
三维染色质结构和RNA表观基因组学新兴领域。
特别关注单细胞和单分子的变革性表观基因组技术
水平以及如何使用它们在来自个体的细胞中构建和使用“表观遗传时钟”
不同年龄,并针对不同年龄相关疾病确定新的“返老还童”策略。
这次会议应该培养令人兴奋的基础知识和信息、新方法
会议还将提供技术能力和跨学科合作。
为学员和新研究者提供独特的互动、多元化和包容性论坛
不同的领域,通过简短的演讲、海报预告片和会议来强调他们的研究,
促进多项网络和专家会面活动。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANNE BRUNET其他文献
ANNE BRUNET的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANNE BRUNET', 18)}}的其他基金
Link between epigenetic modifiers and fat metabolism for healthy aging
表观遗传修饰剂与健康老龄化脂肪代谢之间的联系
- 批准号:
9923525 - 财政年份:2016
- 资助金额:
$ 5万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
A novel bioengineering approach to restoring permanent periodontal inflammatory bone loss
一种恢复永久性牙周炎性骨质流失的新型生物工程方法
- 批准号:
10734465 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Examining the Role of Social Connection in Suicide Risk for Older Autistic Adults: A Mixed Methods Study
检查社会联系在老年自闭症成人自杀风险中的作用:一项混合方法研究
- 批准号:
10727637 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Loss of transcriptional homeostasis of genes lacking CpG islands during aging
衰老过程中缺乏 CpG 岛的基因转录稳态丧失
- 批准号:
10814562 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Engineered tissue arrays to streamline deimmunized DMD gene therapy vectors
工程组织阵列可简化去免疫 DMD 基因治疗载体
- 批准号:
10724882 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
CRISPR-Cas Editing as a Genetic Cure for Autosomal Dominant Polycystic Kidney Disease
CRISPR-Cas 编辑作为常染色体显性多囊肾病的基因治疗
- 批准号:
10822502 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别: